By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Key Finding: AI Shows Limited Advantage Over Traditional Methods in Flu Vaccine Design

Key Finding: AI Shows Limited Advantage Over Traditional Methods in Flu Vaccine Design

GMJ
Last updated: 21/06/2026 16:51
By
Prof. Giorgi Pkhakadze
Share
0 Min Read
Comparison chart showing AI versus traditional methods in influenza vaccine strain selection accuracy
New research in Nature Medicine shows AI algorithms achieve only modest improvements over traditional expert methods in selecting flu vaccine strains. Hybrid approaches combining AI with human expertise show the most promise for future vaccine development. — Photo: Thirdman / Pexels
SHARE
1 min read|32 words

AI algorithms achieved just 15% better accuracy than WHO expert committees in flu vaccine strain selection over 15 seasons. Modest gains challenge AI hype in vaccine development.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Key Finding

📰 Read the full article: AI Shows Limited Advantage Over Traditional Methods in Flu Vaccine Design →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Timing of Second Stent Placement After Heart Attack: New Trial Challenges Immediate Intervention Strategy

A randomized controlled trial published in the New England Journal of Medicine…

Africa’s Regional Research Hubs: Building Local Capacity for Drug Manufacturing and Health Innovation

Africa needs strategically distributed regional research and development hubs to accelerate local…

New optical imaging technique could improve donor liver assessment before transplantation

Researchers have developed polarization-sensitive optical coherence tomography (PS-OCT) to assess donor liver…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Pediatrician examining child with digital device showing AI interface

Zero Randomized Trials Evaluate AI Tools for Child Development Despite Widespread Pediatric Use

By
Prof. Giorgi Pkhakadze
16/07/2026
Medical illustration comparing manufactured biotherapeutic capsules to traditional fecal microbiota transplant procedure

Takeaway: Live biotherapeutic matches donor FMT in treating recurrent C. diff infection

By
Prof. Giorgi Pkhakadze
06/07/2026
Scientific laboratory equipment for antimalarial drug testing and genotyping analysis

Genotyping Bias in Antimalarial Trials: Why Accurate Testing Matters Now

By
Prof. Giorgi Pkhakadze
14/06/2026
Illustration of muscle strength signalling neuroprotective mechanisms in the aging brain: endothelial function, neurotrophic factors, and neuroinflammation control.

Seven Pathways, One Goal: The Science Behind Strength and Brain Protection

By
Prof. Giorgi Pkhakadze
07/08/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up